Research · Sep 3, 2026
[AHR] American Healthcare REIT Thesis 2026: Senior Housing Cycle Drives Outpatient Medical Capital Return
American Healthcare REIT, Inc. (NYSE: AHR) FY2025 revenue ~$2.20-2.35B (+5-10%) with adj. core FFO/share ~$1.55-1.70 reflecting continued post-2024 ~$1.55-1.65B aggregate Senior Housing Operating Partnerships (SHOP) revenue (~70%+ aggregate revenue mix; selected primary US senior housing + selected various aggregate Trilogy + selected various aggregate Integrated Senior Health Campuses) + selected continued post-2024 ~$300-340M aggregate Outpatient Medical revenue (~14% aggregate revenue mix) + selected continued post-2024 ~$200-240M aggregate Triple-Net Leased Senior Housing + Skilled Nursing revenue (~10% aggregate revenue mix) + selected continued post-2024 ~$120-145M aggregate Other revenue (~6% aggregate revenue mix) under continued President + CEO Danny Prosky since 2022 (~3-year tenure as American Healthcare REIT CEO; selected post-February 2024 NYSE IPO). One of the largest US healthcare-focused REITs. Founded 2021 as American Healthcare REIT post-merger of Griffin-American Healthcare REIT III + Griffin-American Healthcare REIT IV in Irvine California (~4-year heritage post-merger); selected post-February 2024 NYSE IPO ($845M+ proceeds); selected post-2022 Danny Prosky CEO appointment. Headquartered in Irvine California; ~150-200+ employees globally with ~$2.20-2.35B revenue. Four primary business segments: SHOP (~70%+ ~$1.55-1.65B), Outpatient Medical (~14% ~$300-340M), Triple-Net Leased SH+SNF (~10% ~$200-240M), Other (~6% ~$120-145M). Geographic mix: US ~95%+ + selected various international ~5%. Senior Housing cycle (~+10-12% same-property NOI growth): ~$1.55-1.65B SHOP revenue; ~325+ aggregate senior housing communities; ~85-87% aggregate occupancy; ~+10-12% aggregate same-property NOI growth. Outpatient Medical + Triple-Net Leased Senior Housing: ~$300-340M Outpatient Medical revenue; ~$200-240M Triple-Net Leased revenue; ~$5-6B aggregate Outpatient Medical aggregate gross book value; ~+2-3% aggregate Outpatient Medical NOI growth. President + CEO Danny Prosky since 2022 (~3-year tenure); CFO Brian Peay. Capital return: ~$1.10 annual dividend FY2025 (~1-year continuous dividend track post-February 2024 NYSE IPO); minimal opportunistic buybacks; aggregate capital return ~$170-180M FY2025; net leverage ratio ~5.5-6.0x; non-investment grade B1/BB credit rating. FY2026 thesis: Senior Housing cycle (~+10-12% same-property NOI growth) + Outpatient Medical + Triple-Net Leased Senior Housing + Skilled Nursing + ~$1.10 annual dividend + ~1-year continuous dividend track + ~$170-200M aggregate annual capital return + selected projected post-2026 deleveraging trajectory. Risks: Welltower + Ventas + Healthpeak Properties + Brookdale + Sunrise + Healthcare Realty Trust competition, CMS reimbursement, Skilled Nursing reimbursement, sustained ~5.5-6.0x net leverage.